Darling Joseph G 4
4 · Anika Therapeutics, Inc. · Filed Feb 28, 2019
Insider Transaction Report
Form 4
Darling Joseph G
President
Transactions
- Award
Restricted Stock Unit
2019-02-26+63,000→ 63,000 totalExercise: $0.00→ Common Stock (63,000 underlying) - Award
Stock Option (Right to Buy)
2019-02-27+7,609→ 7,609 totalExercise: $61.47Exp: 2028-01-24→ Common Stock (7,609 underlying)
Footnotes (4)
- [F1]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020, provided that the first installment of shares hereunder shall be delivered upon the first to occur of Mr. Darling's (a) death, (b) disability, (c) separation from service (as defined by the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (the "Plan")), or (d) a Change in Control (as defined by the Plan).
- [F2]The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 24, 2018, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 3 and 4.
- [F3]On February 27, 2019, the Compensation Committee determined and certified that 53.2% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 2 and 4.
- [F4]The stock options vest in four equal installments on the following dates: February 27, 2019, January 1, 2020, January 1, 2021, and January 1, 2022.